The utility of inflammation and nutritional markers, such as CRP-based CAR and platelet-based PLR related to inflammation, lymphocyte-based NLR related to immunity, and albumin-based PNI related to nutrition, has been extensively investigated in patients with gastric cancer; however, few reports focused on the elderly patients with gastric cancer [14, 23, 24, 26]. This evidence concerns the gene ALB and gastric cancer.